ORAL ANTICOAGULATION IN PATIENTS SURVIVING MYOCARDIAL-INFARCTION - A NEW APPROACH TO OLD DATA

被引：16

作者：

LOELIGER, EA ^{[1
]}

机构：

[1] LEIDEN STATE UNIV HOSP,DEPT HAEMATOL,THROMBOSIS RES UNIT,2333 AA LEIDEN,NETHERLANDS

来源：

关键词：

D O I：

10.1007/BF00546723

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：137 / 139

页数：3

共 24 条

[1] ASPENSTROM G, 1964, ACTA MED SCAND, V176, P563
[2] Baptista J., 1977, Applied Statistics, V26, P214, DOI 10.2307/2347041
[3] BJERKELUND CJ, 1957, ACTA MED SCAND S330, V158, P13
[4] BORCHGREVINK CF, 1960, ACTA MED SCAND S, V359, P7
[5] BREDDIN K, 1980, HAEMOSTASIS, V9, P325
[6] CLAUSEN J, 1961, Ugeskr Laeger, V123, P973
[7] PREVENTION OF RECURRENCES OF MYOCARDIAL INFARCTION - DOUBLE-BLIND STUDY OF EFFECTIVENESS OF LONG-TERM ORAL ANTICOAGULANT THERAPY
CONRAD, LL
WIGGINS, CW
HONICK, GL
KYRIACOPOULOS, JD
[J]. ARCHIVES OF INTERNAL MEDICINE, 1964, 114 (03) : 348 - +
[8] LONG-TERM ANTICOAGULANT THERAPY AFTER MYOCARDIAL INFARCTION - FINAL REPORT OF VETERANS ADMINISTRATION COOPERATIVE STUDY
EBERT, RV
BORDEN, CW
HIPP, HR
HOLZMAN, D
LYON, AF
SCHNAPER, H
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 207 (12): : 2263 - &
[9] HARVALD B, 1962, LANCET, V2, P626
[10] ORAL ANTICOAGULANT IN PATIENTS SURVIVING MYOCARDIAL-INFARCTION - A NEW APPROACH TO OLD DATA
LEIZOROVICZ, A
BOISSEL, JP
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (03) : 333 - 336